Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Exploring Trauma Plus (ET+) (ET+)

13 de novembro de 2026 atualizado por: Envisioning Justice Solutions, Inc

Exploring Trauma Plus (ET+): A Brief Intervention for Men and Gender-Diverse Populations

This randomized controlled trial evaluates Exploring Trauma Plus (ET+), a brief, manualized, trauma-specific intervention designed for justice-involved men and transgender and gender-diverse individuals. The six-session curriculum uses psychoeducation, cognitive-behavioral strategies, mindfulness, grounding techniques, and structured exercises to help participants understand trauma, manage trauma-related distress, and develop coping skills.

The study is beging conducted at a California correctional facility for men and compares participants randomly assigned to ET+ with participants assigned to a waitlist control condition. The program is delivered by trained peer facilitators in general institutional housing on a custody level III yard.

Researchers assess changes in trauma-related distress, behavioral health symptoms, anger, and aggression using validated self-report measures administered before and after the intervention period.

Visão geral do estudo

Descrição detalhada

The primary objective of the randomized controlled trial is to assess the effectiveness of the Exploring Trauma Plus (ET+) curriculum at reducing co-occurring trauma, anger, and aggression among men and the transgender and gender-diverse (TGD) community. Using a randomized experimental design, this study aims to quantitatively measure change on specifically targeted outcome measures over time spent in the ET+ program among a group of males and TGD individuals who participate in the program (treatment group) versus a group of similar males and TGD individuals who did not participate in the program (control group). Refined inferential statistical analyses will be employed to analyze the data collected and explore an integrated model of trajectories of trauma and aggression among participants in prison.

ET+ is a 6-week 6-session trauma-informed program that utilizes Peer Facilitators. Peer facilitators are individuals serving long-term sentences who volunteered for these positions and were specially trained to facilitate the program for other institutional residents who participate in the program.

Institutional Review Board (IRB) approval was received on May 23, 2024. CDCR Research Oversight Committee approvals and Data Sharing Agreements were sought and also approved. Oversight will continue throughout the duration of the study.

Researchers will use a randomization design to test the effectiveness of the ET+ curriculum to reduce trauma-related difficulties (i.e., mental health symptoms, trauma, anger, hostility and aggression) and to increase Restorative Justice outcome measures (i.e., resilience, social connectedness, empathy, and accountability for the harm that has been produced).

Measured outcomes will include PTSD symptoms (Trauma Symptoms Checklist [TSC-40] and the Short Screening Scale for DSM-IV PTSD), depression (Patient Health Questionnaire - Depression Subscale), anxiety (Patient Health Questionnaire - Anxiety), aggression (Buss-Warren Aggression Questionnaire), mental health functioning (K6 Brief Mental Health Screen), instrumental and expressive anger (Revised Instrumental and Expressive Representation Scales), the Brief Resilient Coping Scale, and the Dickman Impulsivity Scale.

Tipo de estudo

Intervencional

Inscrição (Estimado)

250

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

    • California
      • Corcoran, California, Estados Unidos, 93212
        • Recrutamento
        • California State Prison, Corcoran
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria: All participants who expressed interest in participating in the study at the California men's prison and who were capable of providing written informed consent.

-

Exclusion Criteria: There were no study-defined exclusion criteria; operational exclusions or security restrictions were at the discretion of prison administration.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Exploring Trauma Plus Brief Intervention

This revised evidence-based six-session trauma intervention is designed for people who have experienced abuse and trauma. The understanding of gender has shifted from the binary male-female model to a more inclusive and expansive model. This second edition of Exploring Trauma is now entitled Exploring Trauma+: A Brief Intervention for Men and Gender-Diverse People in order to reflect the changes in this new edition. The definition of gender responsiveness has been expanded to include the experiences of transgender and nonbinary people. This new material has inclusive pronouns, as well as examples of traumatic events and focus questions specific to this group. The materials focus on the three core things that both staff and clients need: an understanding of what trauma is, its process, and its impact on both the inner self (thoughts, feelings, beliefs, values) and the outer self (behavior and relationships).

ET+ is an evidence-based 6-session brief intervention with a focus on trauma and PTSD, and techniques for Restorative Justice work with men (and those who identify as men). The rigorously evaluated manualized curriculum is designed for trauma treatment while emphasizing Restorative Justice principles and objectives, e.g., understanding victim impact, personal accountability, and restitution. The intervention is delivered to small groups of 10-12 men and co-led by two specially trained Peer Facilitators. Using a closed group model creates the experience of a prosocial support system based on a new value system and group agreements. This is strengthened by using Peer Facilitators as role models. The group process helps develop empathy and connectedness for other group members.

Sem intervenção: Waitlist Control Group

Participants assigned to the waitlist control condition, serving as the comparison group during the study. Participants are offered Exploring Trauma Plus (ET+) after their study participation.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Modified Short Screening Scale for DSM-IV PTSD (7-item symptom index, following a trauma-exposure screen)
Prazo: Baseline, before the intervention; and follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group. Approximately 8 weeks.

The Modified Short Screening Scale for DSM-IV PTSD is a 7-item measure assessing the frequency of posttraumatic stress symptoms following exposure to a traumatic event. Items assess symptom frequency over the preceding four weeks, with responses ranging from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 21, with higher scores indicating greater symptom frequency.

Baseline, before the intervention; and follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group. Approximately 8 weeks.
Patient Health Questionnaire (PHQ) Anxiety Subscale
Prazo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Patient Health Questionnaire (PHQ) Anxiety Subscale is a 7-item measure assessing the frequency of anxiety symptoms over the preceding four weeks. Items are rated on a 4-point scale from 0 (not at all) to 3 (nearly every day). The total score range is 0-18, with higher scores indicating greater anxiety symptom frequency.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
PHQ-9 Depression Subscale
Prazo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Patient Health Questionnaire-9 (PHQ-9) is a 9-item measure assessing the frequency of depressive symptoms over the preceding two weeks. Items are rated on a 4-point scale from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 composite score.
Prazo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Trauma Symptom Checklist-40 (TSC-40) is a 40-item measure assessing trauma-related symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). The composite score ranges from 0 to 120, with higher scores indicating greater trauma-related distress.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 Anxiety Subscale
Prazo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Anxiety subscale of the Trauma Symptom Checklist-40 (TSC-40) consists of 9 items assessing trauma-related anxiety symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 27, with higher scores indicating greater anxiety symptoms.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 Depression Subscale
Prazo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Depression subscale of the Trauma Symptom Checklist-40 (TSC-40) consists of 9 items assessing trauma-related depressive symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 27, with higher scores indicating greater depressive symptoms.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
TSC-40 Outcome Measures 1. Dissociation Subscale
Prazo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Dissociation subscale of the Trauma Symptom Checklist-40 (TSC-40) consists of 6 items assessing dissociative symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 18, with higher scores indicating greater dissociative symptoms.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 Outcome Measures 2. Sexual Abuse Trauma Index (SATI)
Prazo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Sexual Abuse Trauma Index (SATI) of the TSC-40 consists of 7 items assessing symptoms associated with sexual abuse trauma over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 21, with higher scores indicating greater symptom frequency.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 Outcome Measures 3. Sleep Disturbances Subscale
Prazo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Sleep Disturbances subscale of the TSC-40 consists of 6 items assessing sleep-related difficulties over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 18, with higher scores indicating greater sleep disturbance.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
Buss-Warren Aggression Questionnaire (AQ)
Prazo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

A measure of aggressive behavior and tendencies. ET+ uses only the Verbal Aggression and Physical Aggression subscales to assess verbal and physical expressions of aggression.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
Brief Resilient Coping Scale
Prazo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

A 4-item measure assessing the ability to cope with stress in an adaptive and resilient manner.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: NENA P Messina, Envisioning Justice Solutions, Inc

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

1 de abril de 2026

Conclusão Primária (Estimado)

30 de junho de 2028

Conclusão do estudo (Estimado)

30 de junho de 2028

Datas de inscrição no estudo

Enviado pela primeira vez

13 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

13 de novembro de 2026

Primeira postagem (Real)

18 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

18 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

13 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

Individual participant data will not be shared because sharing is subject to applicable data-use restrictions and authorization from the California Department of Corrections and Rehabilitation (CDCR).

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever